The Food and Drug Administration (FDA), led by Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER), is tirelessly and relentlessly promoting continuous manufacturing (CM) as the best opportunity to achieve its 21st Century Quality vision "...a maximally efficient, agile, flexible pharmaceutical manufacturing sector that reliably produces high-quality drugs without extensive regulatory oversight."
Choose Your Location
To customize your experience, select an IPS region or country to view specific information based on your location.
- United States
- All Other Countries
You’ve chosen as your location.
Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.